EUCTR2020-001717-20-ES进行中（未招募）1 期
Prevention and treatment with Calcifediol of Coronavirus COVID-19-induced acute respiratory syndrome (SARS)
Fundación para la Investigación Biomédica de Córdoba0 个研究点目标入组 1,008 人开始时间: 2020年4月27日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,008
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Age = 18 and <90 years
- •2. Diagnosis confirmed by COVID-19 PCR
- •3. Radiological image compatible with inflammatory pleuropulmonary exudate
- •4. Signature of direct or delegated informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 308
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 700
排除标准
- •1. Being on treatment with Calcifediol or Colecalciferol in any of its presentations and dosage
- •2. Intolerance or allergy to Calcifediol or its components
- •3. Pregnancy
研究者
相似试验
已完成
2 期
calcirtiol effect in contrast induced nephropathyeffect of calcitriol in preventing contrast induced nephropathy in patients with renal function undergoing coronary angiography or intervention..IRCT20160412027346N7Shahid Beheshti University of Medical Sciences236
招募中
3 期
Cyclosporin for the Prevention and Treatment of COVID-19 DiseaseIRCT20150107020592N22Shahid Beheshti University of Medical Sciences60
进行中（未招募）
1 期
Cabergoline as a Preventive Treatment for Chronic MigraineMedDRA version: 20.0Level: LLTClassification code 10020739Term: HyperprolactinemiaSystem Organ Class: 100000004860MigraineEUCTR2021-005579-38-DKAarhus University Hospital, Department of Endocrinology32
招募中
不适用
The study of effect of Alfacalcidol treatment on Crohn's diseases diseaseCrohn's diseaseJPRN-UMIN000025961agoya University Hospital31
已完成
不适用
SUPPLEMENTATION WITH CALCIUM FOR THE PREVENTION OF PRE-ECLAMPSIA IN WOMEN WITH LOW CALCIUM INTAKE-O149 Pre-eclampsia, unspecifiedPre-eclampsia, unspecifiedO149PER-013-02INSTITUTO DE INVESTIGACION NUTRICIONAL,